(Q33695737)

28 July 2017

1 reference

title

Hormone replacement therapy (English)

1 reference

28 July 2017

Kooistra T

1

1 reference

28 July 2017

Emeis JJ

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Current Opinion in Chemical Biology

28 July 2017

published in

1 reference

28 July 2017

volume

3

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

495-499

1 reference

Hormone replacement therapy

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Hormone replacement therapy, heart disease, and other considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Myth and paradox of coronary risk and the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

The novel estrogen receptor-beta subtype: potential role in the cell- and promoter-specific actions of estrogens and anti-estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Definition of the molecular mechanism of action of tissue-selective oestrogen-receptor modulators

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Tamoxifen decreases serum cholesterol by inhibiting cholesterol synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

1 reference

7 January 2021

Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Antagonism of sexual behavior in female rats by ventromedial hypothalamic implants of antiestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Hormone and nonhormone therapy for the maintenance of postmenopausal health: the need for randomized controlled trials of estrogen and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

ER beta: identification and characterization of a novel human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

ERbeta: a novel estrogen receptor offers the potential for new drug development

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Estrogen Up-regulates Apolipoprotein E (ApoE) Gene Expression by Increasing ApoE mRNA in the Translating Pool via the Estrogen Receptor α-Mediated Pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

Cloning and characterization of human estrogen receptor beta isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2899%2980072-6

7 January 2021

10.1016/S1367-5931(99)80072-6

Identifiers

DOI

1 reference

28 July 2017

1 reference